Human Absorption, Distribution, Metabolism, and Excretion Studies: Origins, Innovations, and Importance
Drug Metabolism and Disposition · 2023-06 · 51 (6) · 647-656
DOI: 10.1124/dmd.122.001006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Metabolism and Disposition, 2023-06. Verfasst von Matthew A Cerny und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacokinetics, Dynamics, and Metabolism, Pfizer, Inc., Groton, Connecticut matthew.cerny@pfizer.com. Hauptthemen laut MEDLINE: Metabolic Clearance Rate. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Pharmacokinetics, Dynamics, and Metabolism, Pfizer, Inc., Groton, Connecticut matthew.cerny@pfizer.com.
- Pharmacokinetics, Dynamics, and Metabolism, Pfizer, Inc., Groton, Connecticut.
Zitieren
APA
Cerny, M. A., Spracklin, D. K., & Obach, R. S. (2023). Human Absorption, Distribution, Metabolism, and Excretion Studies: Origins, Innovations, and Importance. Drug Metabolism and Disposition, 51(6), 647-656. https://doi.org/10.1124/dmd.122.001006
Vancouver
Cerny MA, Spracklin DK, Obach RS. Human Absorption, Distribution, Metabolism, and Excretion Studies: Origins, Innovations, and Importance. Drug Metabolism and Disposition. 2023;51(6):647-656. doi:10.1124/dmd.122.001006
BibTeX
@article{Cerny2023,
author = {Cerny, Matthew A and Spracklin, Douglas K and Obach, R Scott},
title = {Human Absorption, Distribution, Metabolism, and Excretion Studies: Origins, Innovations, and Importance},
journal = {Drug Metabolism and Disposition},
year = {2023},
volume = {51},
number = {6},
pages = {647--656},
doi = {10.1124/dmd.122.001006}
}
EUVIMED